Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
ENTBF Stock Chart & Stats
$0.08
$0.08(63.18%)
At close: 4:00 PM EST
$0.08
$0.08(63.18%)
Day’s Range― - ―
52-Week Range$0.05 - $0.29
Previous CloseN/A
Volume3.65K
Average Volume (3M)2.06K
Market Cap
$1.01M
Enterprise Value$934.39K
Total Cash (Recent Filing)$382.21K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.01
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding13,858,926
10 Day Avg. Volume889
30 Day Avg. Volume2,056
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)7.46
Price to Sales (P/S)0.00
P/FCF Ratio-3.05
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Entheon Biomedical News
ENTBF FAQ
What was Entheon Biomedical’s price range in the past 12 months?
Entheon Biomedical lowest stock price was $0.05 and its highest was $0.29 in the past 12 months.
What is Entheon Biomedical’s market cap?
Entheon Biomedical’s market cap is $1.01M.
When is Entheon Biomedical’s upcoming earnings report date?
Entheon Biomedical’s upcoming earnings report date is Mar 31, 2026 which is in 92 days.
How were Entheon Biomedical’s earnings last quarter?
Entheon Biomedical released its earnings results on Sep 22, 2025. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Entheon Biomedical overvalued?
According to Wall Street analysts Entheon Biomedical’s price is currently Overvalued.
Does Entheon Biomedical pay dividends?
Entheon Biomedical does not currently pay dividends.
What is Entheon Biomedical’s EPS estimate?
Entheon Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical have?
Entheon Biomedical has 13,858,926 shares outstanding.
What happened to Entheon Biomedical’s price movement after its last earnings report?
Entheon Biomedical reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -14.286%.
Which hedge fund is a major shareholder of Entheon Biomedical?
Currently, no hedge funds are holding shares in ENTBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Entheon Biomedical
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Technical Analysis
Cybin
―
Braxia Scientific
―
Lexston Life Sciences Corp.
―
Doseology Sciences
―
Lophos Holdings, Inc.
―